1 / 19

Local (Tissue) Renin-Angiotensin System

Local (Tissue) Renin-Angiotensin System Important for its role in hypertrophy, inflammation, remodelling and apoptosis Binding of renin or pro-renin to pro-renin receptors located on cell surface Present in many tissues like brain, pituitary blood vessels, heart, kidney, adrenal glands

ally
Download Presentation

Local (Tissue) Renin-Angiotensin System

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Local (Tissue) Renin-Angiotensin System • Important for its role in hypertrophy, inflammation, remodelling and apoptosis • Binding of renin or pro-renin to pro-renin receptors located on cell surface • Present in many tissues like brain, pituitary blood vessels, heart, kidney, adrenal glands • Extrinsic local RAS: in vascular endothelium of these tissues • Intrinsic local RAS: tissues having mRNA expression

  2. Number of enzymes that act as alternative pathway for conversion of angiotensinogen to AngI or directly to AngII • Enzymes are: cathepsin, tonin, cathepsin G, chymostatin sensitiveAngII generating enzyme and heart chymase • Angiotensin receptors:two types- • AT1 and AT2 • Most effects of AngII are mediated by AT1 receptors • Role of AT22 receptors not well defined • May counterbalance many effects of AT1 activation

  3. Functions of RAS • Effects of AngII on CVS include: • Rapid pressor respone-  peripheral resistance • Slow pressor response- via decrease in renal excretion and production of endothelin-1 • Vascular and cardiac hypertrophy and remodeling

  4. Rapid Pressor Response AT1 CNS Blood Vessel Peripheral Vasoconstriction •  SymPathetic Outflow •  Baroreflex mediated  in sympathetic outflow  • Enhancement of NE transmission •  of NE reuptake •  of NE response • Ganglionic stimulation

  5. Brain contains all components of RAS • Brain is affected by both circulating AngII and AngII formed within the brain • Action of AngII on brain causes: • Increased central sympathetic tone • Dipsogenic effect (thirst) • Release of catecholamines from adrenal medulla: AngII depolarises the chromaffin cells of adrenal medulla and causes release of adrenaline

  6. Slow Pressor Response: • Produced by effect on the kidneys • AngII: • Reduces urinary excretion of Na+ and water • Increases excretion of K+ • Stimulates Na+/H+ exchange in proximal tubule due to which Na+, Cl- and bicarbonate reabsorption increases • Increases expression of Na+-glucose symporter in proximal tubule • Directly stimulates Na+-K+-2Cl- symporter in thick ascending limb

  7. Proximal tubule secretes angiotensinogen and the connecting tubule secretes renin • Paracrine tubular RAS? Functions? • AngII stimulates zona glomerulosa of adrenal cortex to increase the synthesis and secretion of aldosterone • Also auguments its response to other stimuli like ACTH, K+ • Aldosterone acts on distal and collecting tubules to cause retention of Na+ and excretion of K+ and H+ • Stimulatory effect of AngII on aldosterone secretion depends on plasma concentrations of Na+ and K+

  8. Release of aldosterone is enhanced in cases of hyponatremia or hyperkalemia and vice versa • Effect on glomerular filtrate: • Constriction of afferent arterioles reduces intraglomerular pressor and tends to reduce GFR • Contraction of mesangial cells decreases the capillary surface area within the glomerulous and tends to decrease GFR • Constriction of efferent arterioles increases the intraglomerular pressor and tends to increase GFR • Normally, GFR is slightly reduced by AngII

  9. Vascular and cardiac hypertrophy and remodeling: • Cells involved- vascular smooth muscle cells, cardiac myocytes and fibroblasts • Stimulates migration, proliferation and hypertrophy of vascular smooth muscle cells • Increases extracellular matrix production by vascular smooth muscle cells • Causes hypertrophy of cardiac myocytes • Increases extracellular matrix production by cardiac fibroblasts

  10. Opening of voltage gated Ca2+ channels contractility (-)  Central sympathetic tone (+) HEART Baroreflex mediated  of sympathetic tone  Release of CA from adrenals  Facilitation of adrenergic transmission Net Effect Uncertain

  11. Inhibitors of RAS • ACE inhibitors (ACEIs) • Angiotensin receptor blockers (ARBs) • Direct renin inhibitors (DRIs)

  12. ACE Inhibitors: • Inhibit conversion of AngI to AngII • Decrease BP, Increase Na+ excretion from kidney • Increase levels of bradykinin which stimulates formation of PGs- lower BP • Increase circulating levels of natural stem cell regulator- cardioprotective effect ? • Increase renin release and formation of AngI due to inhibition of short loop negative feed back (AngII) • AngI accumulates & metabolized to vasodialtor peptides

  13. Healthy persons with normal sodium: ACE inhibitors have minor effects on BP • Salt depleted person: substantial lowering of BP • Mainly eliminated by kidney so dosage should be adjusted in compromised renal functions • Marked lowering of BP in patients with increased renin activity, adjust dose • All ACE inhibitors are prodrugs

  14. Uses of ACE Inhibitors: • Essential hypertension • Left ventricular systolic dysfunction: prevents or delays progression of heart failure • Acute MI • High risk patients of cardiovascular disorders • Diabetes mellitus with renal failure- has renoprotective effects in type I D. mellitus • Scleroderma renal crisis

  15. ADRs: • Hypotension- first dose in high renein patients • Cough- due to accumulation of bradykinin, substance P and/or PGs in lungs. Thromboxane, aspirin and iron helpful • Hyperkalemia in patients of renal failure/D.mellitus • Acute renal failure- in patients of renal artery stenosis, single renal artery or heart failure - due to dilatation of efferent arteriole • Fetopathic effect: may be due to fetal hypotension- ACE inhibitors to be stopped during pregnancy

  16. Skin rash • Angioedema: in some patients, disappears after stopping ACE inhibitors • Interactions: • NSAIDs may reduce antihypertensive effect • K+ sparing diuretics and K+ supplements may precipitate hyperkalemia

  17. ARBs: • Competitively Bind to AT1 receptors • Binding and blockade are often insurmountable- • slow dissociation from AT1 receptors • ARBs induced receptor internalization • Increase renin release and AngII levels like ACE inhibitors • Candesartan Irbesartan Eprosartan • Losartan Olmesartan Telmisartan • Vasartan

  18. Uses of ARBs: • Essential hypertension • Irbesartan & losartan- diabetic nephropathy • Losartan- stroke prophylaxis • Valsartan- heart failure

  19. Direct Renin Inhibitors: • Aliskiren- approved drug • Competitive inhibitor of renin • Reduces formation of AngII but increases plasma renin conc. due to loss of short loop negative feed back • Dose-dependant decrease in BP • Decreases plasma aldosterone levels and enhances natriuresis • Single oral dose 150-300 mg/day • Used for treatment of hypertension

More Related